Daily DOTS course for newly detected TB patients launched in Kashmir

Published On 2017-10-31 03:40 GMT   |   Update On 2017-10-31 03:40 GMT
Advertisement

Srinagar: The Directorate of Health Services, Kashmir (DHSK) launched a daily DOTS medicine course free of charge for newly detected tuberculosis patients across the Valley under Revised National Tuberculosis Control Programme (RNTCP).


Earlier, TB patients were being treated on intermittent DOTS regimen where patients were administered medicines three days a week.


Director of DHSK Saleem Ur Rehman launched the daily- based DOTS Regimen (medicine doses) at District Tuberculosis Centre, Srinagar where he distributed the medicines to newly detected TB patients, an official spokesperson said.

Advertisement

The event was organised by District TB Centre under the aegis of State TB Control Society and DHSK, he said.


On the occasion, Rehman said in India, around 600 people die of tuberculosis every day.


"But in the Valley, the cure rate is 85 percent compared to the rest of the country and DHSK is working very hard to improve the rate further," he said.


"The new treatment protocol replaces the existing three times a week treatment and will be implemented across Kashmir. Instead of several individual drugs, patients will be put on fixed drug combinations, that is three or more drugs as a single dose, to reduce the pill burden and to simplify the treatment," the director said.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News